Multiple funding proposals being considered by PHARMAC

PHARMAC

19 May 2022 - PHARMAC has issued three consultations today on proposals to fund medicines for conditions including cancer, multiple sclerosis, hormone replacement and HIV. 

The treatments being considered are estimated to benefit thousands of New Zealanders a year.

Read PHARMAC press release

Michael Wonder

Posted by:

Michael Wonder